M
Marc Gittelman
Researcher at University of Texas Southwestern Medical Center
Publications - 62
Citations - 2614
Marc Gittelman is an academic researcher from University of Texas Southwestern Medical Center. The author has contributed to research in topics: Lower urinary tract symptoms & Testosterone (patch). The author has an hindex of 21, co-authored 55 publications receiving 2311 citations. Previous affiliations of Marc Gittelman include University of Wisconsin-Madison & University of California, Davis.
Papers
More filters
Journal ArticleDOI
Natural history of rising serum prostate-specific antigen in men with castrate nonmetastatic prostate cancer.
Matthew R. Smith,Fairooz F. Kabbinavar,Fred Saad,Arif Hussain,Marc Gittelman,David L. Bilhartz,Chris Wynne,Robin Murray,Norman Zinner,Claude Schulman,Ronald Linnartz,Ming Zheng,Carsten Goessl,Y. J. Hei,Eric J. Small,Richard J. Cook,Celestia S. Higano +16 more
TL;DR: Men with nonmetastatic prostate cancer and rising PSA despite androgen deprivation therapy have a relatively indolent natural history and baseline PSA and PSA velocity independently predict time to first bone metastasis and survival.
Journal ArticleDOI
Comparative efficacy and safety of transdermal oxybutynin and oral tolterodine versus placebo in previously treated patients with urge and mixed urinary incontinence.
Roger R. Dmochowski,Peter K. Sand,Norman Zinner,Marc Gittelman,G. Willy Davila,Steven W. Sanders +5 more
TL;DR: OXY-TDS improves systemic safety with regard to anticholinergic side effects and TOL-LA are effective and comparable treatments for patients with urge and mixed incontinence.
Journal ArticleDOI
Serum prostate-specific antigen and prostate volume predict long-term changes in symptoms and flow rate: results of a four-year, randomized trial comparing finasteride versus placebo
Claus G. Roehrborn,Peter Boyle,Donald Bergner,Todd Gray,Marc Gittelman,Thomas Shown,Arnold Melman,Arnold Melman,R. Bruce Bracken,R. Bruce Bracken,Ralph W deVere White,Alice Taylor,Alice Taylor,Daniel Wang,Daniel Wang,Joanne Waldstreicher,Joanne Waldstreicher +16 more
TL;DR: Baseline PSA levels of 1.4 ng/mL or greater and enlarged prostate glands predict the best long-term response to finasteride compared with placebo, and these levels are good predictors of long- term symptomatic and flow rate changes.
Journal ArticleDOI
Rapid Efficacy of the Highly Selective α1A-Adrenoceptor Antagonist Silodosin in Men With Signs and Symptoms of Benign Prostatic Hyperplasia: Pooled Results of 2 Phase 3 Studies
TL;DR: Treatment with silodosin produced rapid improvement in urinary symptoms that was sustained for 12 weeks and was well tolerated with a low incidence of orthostatic hypotension.
Journal ArticleDOI
Minimally Invasive Prostate Convective Water Vapor Energy Ablation: A Multicenter, Randomized, Controlled Study for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.
Kevin T. McVary,Steven N. Gange,Marc Gittelman,Kenneth Goldberg,Kalpesh Patel,Neal D. Shore,Richard Levin,Michael Rousseau,J. Randolf Beahrs,Jed Kaminetsky,Barrett E. Cowan,Christopher H. Cantrill,Lance A. Mynderse,James Ulchaker,Thayne R. Larson,Christopher M. Dixon,Claus G. Roehrborn +16 more
TL;DR: Convective water vapor thermal therapy provides rapid and durable improvements in benign prostatic hyperplasia symptoms and preserves erectile and ejaculatory function.